|4Oct 2, 9:20 AM ET

Dunne Michael W. 4

4 · Iterum Therapeutics plc · Filed Oct 2, 2023

Insider Transaction Report

Form 4
Period: 2023-10-01
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-10-01+3,48758,754 total
  • Exercise/Conversion

    Restricted Share Units

    2023-10-013,4870 total
    Ordinary Shares (3,487 underlying)
Footnotes (2)
  • [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
  • [F2]On December 23, 2022, the reporting person was granted an award of 3,487 RSUs, which vested in full on October 1, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION